Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark H Drazner

JAMA

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
JAMA|December 1, 2025
Levosimendan and Weaning From VA-ECMOMark H Drazner
JAMA|September 3, 2019
Angiotensin Receptor-Neprilysin Inhibition (ARNI) Therapy and Reverse Remodeling in Heart Failure With Reduced Ejection FractionMark H Drazner
JAMA|July 19, 2022
Omecamtiv Mecarbil as a Therapy for Heart Failure With Low Ejection FractionMark H Drazner
JAMA|September 27, 2022
Left Ventricular Assist Devices in Advanced Heart FailureMark H Drazner
JAMA|June 5, 2008
Economic barriers in organ transplantationMark H Drazner, Louise P King
JAMA|December 9, 2010
Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general populationJames A de Lemos, Mark H Drazner, Torbjorn Omland, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
JAMA|December 1, 2025
Levosimendan and Weaning From VA-ECMOMark H Drazner
JAMA|September 3, 2019
Angiotensin Receptor-Neprilysin Inhibition (ARNI) Therapy and Reverse Remodeling in Heart Failure With Reduced Ejection FractionMark H Drazner
JAMA|July 19, 2022
Omecamtiv Mecarbil as a Therapy for Heart Failure With Low Ejection FractionMark H Drazner
JAMA|September 27, 2022
Left Ventricular Assist Devices in Advanced Heart FailureMark H Drazner
JAMA|June 5, 2008
Economic barriers in organ transplantationMark H Drazner, Louise P King
JAMA|December 9, 2010
Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general populationJames A de Lemos, Mark H Drazner, Torbjorn Omland, et al.
Pageof 1